Acute primary Q fever is followed by various chronic sequelae. These include subacute Q fever endocarditis, granulomatous reactions in various organs or a prolonged debilitating post-infection fatigue syndrome (QFS). The causative organism, Coxiella burnetii, persists after an initial infection. The differing chronic outcomes may reflect variations within cytokine and accessory immune control genes which affect regulation of the level of persistence. As a preliminary test of the concept we have genotyped QFS patients and controls for gene variants spanning 15 genes and also examined HLA-B and DR frequencies. QFS patients exhibited a significantly increased frequency of HLA-DR-11 compared with controls and also significant differences in allelic variant frequencies within the NRAMP, and IFNg genes. These results indicate a possible genetic role in the expression of overt chronic Q fever. Further studies will be undertaken to increase sample sizes, to survey other forms of chronic Q fever and to examine Q fever patients who have recovered without sequelae.
Q fever is Australia's commonest and most expensive occupational zoonosis, both in terms of patient morbidity and cost to industry and health services. The causative organism (Coxiella burnetii) multiples in the macrophage phagolysosome. In cultured cells it is not directly cytopathic and grows unchecked to form large cytoplasmic microcolonies. In vivo the cellular immune response (CMI) destroys infected cells; effector mechanisms involve generation of IFNg, TNFa and activation of the apoptosis pathway. 1 After the acute primary infection, the coxiella persists at low level in humans as evidenced, for example, by persistence of antibody and detection of C. burnetii genomic DNA in bone marrow cells from a majority of patients for 5 years or more after the initial illness. 2 Mostly, the persistent infection produces no overt illness, presumably because of a balanced regulation of the infection by the cellular and humoral immune systems. In a minority, balance is not achieved or maintained and chronic illness results. This may take the form of either a prolonged incapacitating post-infection fatigue syndrome (QFS), 3 B8À15% of acute cases, or of recrudescent granulomatous lesions in liver, testis, bone, lung, pleura or soft tissues, or of infection of a heart valve with surface or intra-stromal vegetations. A hypothetical paradigm 4 for the study of the chronic Q fever sequelae, derived by analogy from mycobacterial host-parasite relationships in which long-term, low-level bacterial persistence is also a feature, is one of anergic or hypersensitive polar disease states with some intermediate 'reactive' stages.
At the anergic pole is subacute Q fever endocarditis with low indices of cell-mediated immunity (CMI), such a lymphocyte mitogenic responses to Q fever antigens. 5, 6 Scanty inflammatory infiltrates but large numbers of coxiellas are seen in valve vegetations, and generally there are very high levels of serum antibody. The coxiellas in valves are readily detected by animal inoculation, cell culture or PCR gene amplification. Studies by French workers 7, 8 of cytokine response or release patterns from monocytes or PBMC from endocarditis patients have shown upregulated IL-10 and TNFa production, downregulated IFNg responses with increased TNF-R 75 production.
Intermediate stages are recrudescent granulomatous lesions in organs (testis, lung, etc), bone or in soft tissues. In contrast to endocarditis, there is marked lymphocytic infiltration of tissue, with activated macrophages (polykaryocytes/giant cells) and even cell necrosis. There are few coxiellas on microscopy although PCR detection of genomic sequences is positive. There is little information on attempts to culture the coxiella although positive results have been reported from liver. 9 Medium levels of IgG class and, variably, some IgM antibody to Q fever antigens are present. Probably recrudescent infection at the end of pregnancy has a pattern between the anergic and intermediate stages with cellular infiltration and necrosis of placental cotyledons, easily demonstrable coxiellas, and infection of the foetus or newborn. The granulomatous state may be a 'clearing reaction' for the coxiella. There appear to be no reports of cytokine response patterns associated with granulomatous disease but on theoretical grounds upregulation of IFNg and TNFa might be expected.
The post-infection fatigue syndrome after Q fever (QFS) is hypothesised to be the CMI hypersensitivity pole of chronic Q fever. There is no overt organ involvement as in the granulomatous states; levels of coxiella in tissues (bone marrow or PBMC) are very low; medium levels of antibody in the IgG class to the two Q fever phase antigens are present. Cytokine response studies with PBMC in short-term culture have shown cytokine dysregulation with high IL-6, variable IFNg, low IL-10 and IL-2 values. 4 Variations in human immune response and other genes are well recognised to influence the course of infection, particularly by obligate intracellular pathogens which have a similar cell dependency to that of C. burnetii. The relation between immune response gene variation and disease outcomes may be clarified by the analysis of polymorphic variations in individual 'candidate genes' deduced to be of direct importance in disease pathogenesis. [10] [11] [12] This approach has been applied extensively to mycobacterium spp. infections and has linked disease severity either in individuals, or susceptibility of subpopulations to infection, with polymorphic variants within a number of genes, including natural resistance associated macrophage protein (NRAMP1), mannose-binding lectin (MBL), vitamin D receptor (VDR) and various cytokine genes. 13 Given the broad similarities in the host-parasite relationships between C. burnetii and pathogenic mycobacteria taken together with the observed variations in cytokine response patterns between the various chronic sequelae of Q fever, we postulated that polymorphic variations in cytokine and accessory immune control genes may determine symptomless recovery or chronic illness after Q fever.
As a preliminary test of this concept, we have compared variability in phenotype distribution among a range of cytokine and accessory immune response genes in patients with post-Q fever fatigue syndrome and control subjects. This was done as an initial broadbased screening method to identify possibly significant polymorphic gene variants for further detailed and functional studies and as a prelude to examination of other chronic sequelae in Q fever. Twenty-three patients, described previously, 4 and fulfilling the criteria for active or recovered QFS were recruited, informed consent obtained, and a blood donation taken; PBMC samples were separated on Lymphoprep gradients and stored in liquid nitrogen. DNA extraction was performed on PBMC samples.
14 All patients and healthy controls were Caucasian.
Genotyping for all known polymorphic variants within the NRAMP1 gene was performed as described by Liu et al. 15 Although no statistically significant variation was seen between the frequency of the individual single nucleotide polymorphisms (SNP) between patients and controls, Table 1 illustrates that in total there were statistically more variants differing from the wild type in the patient population than in the controls.
HLA typing was performed for HLA-DR and HLA-B alleles. Differences between control subjects and patients were observed between allelic frequencies of HLA-DR alleles, and reached statistical significance with HLA-DR11 (see Table 2 ) but not with HLA-B alleles. The HLA region has been studied extensively with respect to disease susceptibility to infective agents, with a few associations being linked to the HLA-DR11 region (see Discussion).
Sequence specific priming polymerase chain reaction (SSP-
0 nucleotide to gain allelic specificity. When two or more polymorphic sites are present within the one gene, forward and reverse allelic specific primers are used. 17 In total, 25 polymorphic variants were analysed spanning 14 genes. Genes examined for polymorphic variants included MBL, VDR, IL-1RA, IL-1b, IL1-R1, IL-4, IL-6, IL-10, TGFb, INFg, ICAM1, TNFa, E-selectin and L-selectin. It was found to be essential to confirm potentially positive results by sequencing products to confirm base changes. Overall, phenotype frequencies did not depart significantly from control population values.
Functionally significant CA microsatellite variants in the IL-10 promoter and in intron 1 of the IFNg gene were also typed utilizing a combination of sequencing and Gene Scan technologies (Applied Biosystems). Significant variation from published control data was not observed for IL-10 G and R microsatellite variants in the QFS group. However, variations in allele distribution were observed between QFS and control groups for the INFg dinucleotide repeat (Table 3a and b) .
Comparison of the expected values for allele 2 homozygotes and heterozygotes in the QFS group predicted from the distribution in the control group, with the values observed in the QFS patients, revealed that the latter were more often homozygous (2/2) and Using w 2 analysis with Monte-Carlo simulation to account for zeros in multiple boxes. Control subjects were 42 Red Cross blood donors (Adelaide, South Australia) from which PBMCs were isolated and subsequently DNA extracted. Restriction enzyme analysis of PCR products was utilized for genotyping of exon and intron variants; 15 The microsatellite in the promoter of the gene was typed by DNA sequencing analysis (microsatellite analysis is not considered as there are multiple variants from wild type at this locus). Selected subjects were sequenced from each genotype to confirm restriction analysis results.
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Discussion
Given the complexity of the genetic control of the immune system, it is unlikely that there would be a simple one-to-one relation between expression of QFS or other chronic complication of Q fever and a particular polymorphic variation in a cytokine or immune control gene. Effects are more likely to be multigenic and cumulative. Thus far in the investigation of Q fever sequelae, it has been shown that QFS patients differ from controls in the number of NRAMP1 polymorphisms, in the preponderance of HLA DR 11 and in the higher prevalence of the homozygous state for IFNg allele 2 in intron 1.
The human NRAMP1 gene has been hypothesised to be an analogue of the murine Bcg gene which regulates priming and activation of macrophages to destroy a range of intracellular bacteria or parasites. 19 While the NRAMP1 gene may perhaps regulate human macrophages in a similar fashion, present evidence is not decisive and reports appear to be limited to its role in membrane transport of proteins or ions. Nevertheless, at the clinical level, the NRAMP1 gene is thought to influence susceptibility to Mycobacterium tuberculosis, with four variants within the gene being significantly associated with acquisition of infection with tuberculosis and leprosy. 20 Although in general HLA-DR genes/gene products have been shown to play a major immunoregulatory role in immune response against M. tuberculosis antigens and in resistance or susceptibility to other infective agents, HLA-DR11 in particular has not been identified as a prominent player. Variance in HLA-DR has been shown to modulate either a Type 1 or Type 2 CD4+ response to M. leprae HSP 21 and it is well established that HLA-DR plays a role in the binding efficiency of various peptides, with variable binding efficiencies being reported for HLA-DR11. 22 Possession of HLA-DR11 has been linked to rapid progression of the AIDS virus in a Caucasian French population and also to protection from chronic Hepatitis C in an Italian population. 23, 24 Current knowledge suggests that the level of production and efficiency of IFNg is a central determinant for the outcomes of C. burnetii host interactions. In turn it is reasonable to suppose that polymorphisms in the IFNg gene and that of its receptor will modulate the process. The single copy IFNg gene is situated on chromosome 12 and has three introns and four exons specifying a polypeptide of 166 amino acids. IFNg is produced by T cells and NK cells and acts via a speciesspecific cell surface receptor a chain (90 kDa) specified by a gene on chromosome 6. Two a chains and a b chain (from a gene on chromosome 21) are required for functional activity of the receptor, eg induction by IFNg of class II antigens and activation of macrophage bactericidal and tumoricidal effects. Among the IFNg polymorphisms, Pravica et al 25 have shown that the level of INFg expressed from PBMC stimulated with mitogens varies with microsatellite allele genotype, homozygous (2/2) subject being the highest producers.
In humans, mutation in the a chain gene has been reported to lead to a truncated receptor. 26, 27 Individuals homozygous for the mutation have a greatly enhanced susceptibility to mycobacterial infection.
Thus far the results with QFS are compatible with our hypothesis that the chronic manifestations of Q fever may result from an individual's variation in immune responses to the coxiella. It is possible that these are directly involved in the pathogenesis of the syndrome, eg by allowing persistence of the organism and/or by failing to restore cytokine homeostasis in the face of lowlevel persistence. Further studies of patients with QFS, Q fever endocarditis and acute Q fever without chronic complications are required to fully establish the concept. 16 Values other than HLA-DR-11 did not reach significance. Variation in immune response genes and chronic Q fever KJ Helbig et al
